Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Elutia Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 18.1M | 16.1M | −1.97M (−10.9%) |
| Value | $16.1M | $11.1M | −$4.93M (−30.7%) |
New holders (5)
Institutions that held Elutia Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 102,504 | $71.0K | 0.00% |
| Rossmore Private Capital | 50,000 | $34.6K | 0.00% |
| FNY Investment Advisers, LLC | 37,000 | $25.0K | 0.01% |
| Indie Asset Partners, LLC | 12,612 | $8.74K | 0.01% |
| Family Management Corp | 10,045 | $6.96K | 0.00% |
Sold out (3)
Institutions that held Elutia Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,371,603 | $1.22M |
| Virtu Financial LLC | 29,598 | $26.0K |
| Barclays PLC | 100 | $89 |